公开(公告)号：US09505752B2

公开(公告)日：2016-11-29

申请号：US14419559

申请日：2013-08-07

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： Tao Wang ,  Zhongxing Zhang ,  John F. Kadow ,  Nicholas A. Meanwell ,  Edward H. Ruediger ,  Clint A. James ,  Daniel H. Deon ,  David J. Carini ,  Barry L. Johnson

IPC: C07D471/04 ,  A61K31/4545 ,  C07D401/06 ,  A61K31/454 ,  A61K45/06

CPC classification number: C07D471/04 ,  A61K31/454 ,  A61K31/4545 ,  A61K45/06 ,  C07D401/06

Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof: formula (I): wherein A is selected from the group consisting of: formula (II) and wherein Z is selected from the group consisting of: formula (III): and. are useful as HIV attachment inhibitors.

公开(公告)号：US20150210684A1

公开(公告)日：2015-07-30

申请号：US14419559

申请日：2013-08-07

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： Tao Wang ,  Zhongxing Zhang ,  John F. Kadow ,  Nicholas A. Meanwell ,  Edward H. Ruediger ,  Clint A. James ,  Daniel H. Deon ,  David J. Carini ,  Barry L. Johnson

IPC: C07D471/04 ,  A61K45/06 ,  A61K31/4545 ,  C07D401/06 ,  A61K31/454

CPC classification number: C07D471/04 ,  A61K31/454 ,  A61K31/4545 ,  A61K45/06 ,  C07D401/06

Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof: formule (I): wherein A is selected from the group consisting of: formule (II) and wherein Z is selected from the group consisting of: formule (III): and. are useful as HIV attachment inhibitors.

Abstract translation: 式I化合物，包括其药学上可接受的盐：式（I）：其中A选自：结构（II），并且其中Z选自：基团（III）：和。 可用作HIV附着抑制剂。